Sign in

Your life, sourced by science. A publication from Medium about health and wellness.


In Elemental. More on Medium.

The FDA is reluctant to approve $1 home-based tests that could drive the pandemic down, experts say

Image: Geralt/Pixabay

Tests that determine if people have Covid-19 are not helping tamp down the pandemic, experts say. There’s just too much of the coronavirus circulating, too many infections, and those nose-invading PCR tests take forever to yield results, rendering them largely useless. Scientists who understand the problem don’t hold out much hope that the effort will get better anytime soon.

Image: Yuri Samoilov via flickr/CC BY 2.0

Imagine if every morning before you showered you spit into a test tube, and by the time you got out, you knew if you had Covid-19. That result would dictate whether you went to work or saw friends or if you stayed home and isolated.

Photo illustration. Photo sources (Getty Images): dra_schwartz; Tek Image/Science Photo Library; SciePro/Science Photo Library

A day in the life of Jason Hord, one of many scientists working around the clock to test samples from people around the U.S. for antibodies

Around 10 a.m., Jason Hord is out of bed without an alarm. It’s late enough in the morning that the light has leaked through his bedroom window, or there’s some noise in his neighborhood that’s woken him up. Groggily, he gets out of bed. His wife is already at work, and his two school-aged children are also up and doing their distance learning. …

Time to reopen? A conversation with Stanford epidemiologist Dr. Steven Goodman.

People wait in line in Prospect Park to receive free face masks in Brooklyn, New York on May 3, 2020. Photo:
Xinhua News Agency/Getty Images

Are they crazy?

America was never prepared for this

Photo: MediaNews Group/Reading Eagle/Getty Images

As has been widely reported, a major bottleneck in addressing the novel coronavirus outbreak in the U.S. is the extremely limited testing capacity. While South Korea has tested over a quarter million people, the U.S. has performed only 33,000 tests to date*, just three times South Korea’s daily testing capacity. Speculations about negligence, incompetence, and deliberate conspiracy have been floating around to explain this discrepancy. In reality, as is almost always the case, the factors impacting the U.S.’s ability to ramp up testing are incredibly complex. …

In the growing — and controversial — market for direct-to-consumer medical tests, kits for sexually transmitted infections occupy a unique niche between personal and public health

Photo: Andrew Brookes/Getty

Across the United States, rates of sexually transmitted infections are on the rise. Diagnoses for chlamydia, gonorrhea, and syphilis have all risen dramatically over the past several years, according to the Centers for Disease Control and Prevention’s most recent surveillance report.

Some say direct-to-consumer diagnostic kits, currently available for everything from food sensitivity to Lyme disease, offer the convenience and low cost that a doctor’s visit lacks. Others argue they’re more harmful than helpful.

Credit: Vesna Jovanovic / EyeEm/Getty Images

In 2017, Julia Cheek broke a record on ABC’s Shark Tank: The show’s judges awarded her a $1 million deal for her company, EverlyWell, marking the largest investment a solo female entrepreneur had received in the show’s history.


Your life, sourced by science. A publication from Medium about health and wellness.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store